What Are the Incentives for Medicare Prescription Drug Plans to Consider Long-Term Outcomes and Cost?

BACKGROUND: Medicare Prescription Drug Plans (PDPs) do not have incentives to consider long-term outcomes and costs associated with both medical and pharmacy benefits (LTOCMP) when making formulary decisions. OBJECTIVE: To identify existing quality measures, payment models, and public reporting tool...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Anna, Perfetto, Eleanor M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Subject Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398251/
https://www.ncbi.nlm.nih.gov/pubmed/27348277
http://dx.doi.org/10.18553/jmcp.2016.22.7.773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398251/
https://www.ncbi.nlm.nih.gov/pubmed/27348277
http://dx.doi.org/10.18553/jmcp.2016.22.7.773

Ejemplares similares